Brightside Health
PrivateLast Round
Series C
Mar 26, 2024
Total Funding Raised
$108M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Brightside Health operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series C round in March 2024.
Brightside Health is a digital health company that provides a virtual mental healthcare platform offering personalized psychiatry, medication management, and evidence-based therapy for depression, anxiety, and other mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Healthcare Analytics, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brightside Health Comparables
Compare Brightside Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cerebral | 88% | |
| SonderMind | 84% | |
| Two Chairs | 83% |
For institutional investors. Book with your work email.
Brightside Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 26, 2024 | ||||
| Series B | Mar 28, 2022 | ||||
| Series A | May 27, 2021 | ||||
| Seed | Jun 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Brightside Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series C |
| Kennedy Lewis Investment Management | Series C |
| Time BioVentures | Series C |
| Bullpen Capital | Series B, Seed, Series A |
| Mousse Investments | Series C |
| Trousdale Ventures | Series B, Seed |
| Mousse Partners | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2026
Building ML-powered clinical decision support for prescribing.
- Aug 11, 2026
Cited by Healthline, Fortune, and Forbes for best online therapy.
For institutional investors. Book with your work email.
Brightside Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Brightside Health's valuation, stock price, and market status.
Is Brightside Health a public or private company?
Brightside Health is a private company.
What is the current stock price of Brightside Health?
Brightside Health is a private company, so its shares have no public market price. Caplight tracks Brightside Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brightside Health worth (valuation)?
Valuation information for Brightside Health is not publicly available.
Can I buy Brightside Health stock?
Brightside Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brightside Health's last funding round?
Brightside Health's most recent funding round was Series C on March 26, 2024.
Who are the main investors in Brightside Health?
Key investors in Brightside Health include S32, Mousse Partners, Sherpa Capital.
Will Brightside Health IPO soon?
No public IPO plans have been announced for Brightside Health.
How can I track Brightside Health secondary market activity?
Caplight tracks bids, offers, and trades in Brightside Health's shares on secondary markets.